Intravenous immunoglobulin attenuates mesenteric ischemia-reperfusion injury

Clinical Immunology

Volumn 114, Issue 2, 2005, Pages 137-146

  Anderson, Jimie ^a,b   Fleming, Sherry D ^c,d   Rehrig, Scott ^a,b   Tsokos, George C ^c,d   Basta, Milan ^e   Shea Donohue, Terez ^c,f,g  

^a Department of Surgery   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e National Institute of Allergy   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Complement; Inflammation; Ischemia reperfusion; IVIG; Neutrophil; Rat

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN; IMMUNOGLOBULIN 7S; LEUKOTRIENE B4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; ISCHEMIA; LAMINA PROPRIA; MALE; MESENTERIC ARTERY; MESENTERIC ARTERY OCCLUSION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TIDAL VOLUME;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COMPLEMENT C3; COMPLEMENT C5; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINE, SMALL; LEUKOTRIENE B4; LUNG; MALE; NEUTROPHIL INFILTRATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STATISTICS, NONPARAMETRIC;

EID: 11444254547     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.08.018     Document Type: Article

References (29)

1. R.H. Trunage, K.S. Guice, and K.T. Oldham Endotoxemia and remote organ injury following intestinal reperfusion J. Surg. Res. 56 1994 571
2. L.A. Hernandez, M.B. Grisham, B. Twohig, K.E. Arfors, J.M. Harlan, and D.N. Granger Role of neutrophils in ischemia-reperfusion-induced microvascular injury Am. J. Physiol. 253 1987 H699 H703
3. A.T. Eror, A. Stojadinovic, B.W. Starnes, S.C. Makrides, G.C. Tsokos, and T. Shea-Donohue Anti-inflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine Clin. Immunol. 90 1999 266 275
4. J.P. Williams, T.T.V. Pechet, M.R. Weiser, R. Reid, L. Kobzik, F.D. Moore, M.C. Carroll, and H.B. Hechtman Intestinal reperfusion injury is mediated by IgM and complement J. Appl. Physiol. 86 1999 938 942
5. S.D. Fleming, T. Shea-Donohue, J.M. Guthridge, L. Kulik, T.J. Waldschmidt, M.G. Gipson, G.C. Tsokos, and V.M. Holers Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire J. Immunol. 169 2002 2126 2133
6. M. Ikai, M. Itoh, T. Joh, Y. Yokoyama, N. Okada, and H. Okada Complement plays an essential role in shock following intestinal ischaemia in rats Clin. Exp. Immunol. 106 1996 156 159
7. C. Larroche, Y. Chanseaud, P. Garcia de la Pena-Lefebvre, and L. Mouthon Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders BioDrugs 16 2002 47 55
8. E.E. Douzinas, M.T. Pitaridis, G. Louris, I. Andrianakis, K. Katsouyanni, D. Karmpaliotis, J. Economidou, D. Syfras, and C. Roussos Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulin Crit. Care Med. 28 2000 8 15
9. C.J. Rhoades, M.A. Williams, S.M. Kelsey, and A.C. Newland Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin Blood Rev. 14 2000 14 30
10. M. Basta Modulation of complement-mediated immune damage by intravenous immune globulin Clin. Exp. Immunol. 104 Suppl. 1 1996 21 25
11. M. Basta, and M.C. Dalakas High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments J. Clin. Invest. 94 1994 1729 1735
12. M. Basta, L.F. Fries, and M.M. Frank High dose of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes Blood 77 1991 376 380
13. M. Basta, F. Van Goor, S. Luccioli, E.M. Billings, A.O. Vortmeyer, L. Baranyi, J. Szebeni, C.R. Alving, M.C. Carroll, I. Berkower, S.S. Stojilkovic, and D.D. Metcalfe F(ab)′2-mediated neutralization of C3a and C5a anaphylotoxins: a novel effector function of immunoglobulins Nat. Med. 9 2003 431 438
14. C.-J. Chiu, A.H. McArdle, R. Brown, H.J. Scott, and F.N. Gurd Intestinal mucosal lesion in low-flow states Arch. Surg. 101 1970 478 483
15. R.W. Sjogren, C. Colleton, and T.S. Shea-Donohue Intestinal myoelectric response in two different models of acute enteric inflammation Am. J. Physiol. 267 1994 G329 G337
16. W.G. Austen, C. Kyriakides, J. Favuzza, Y. Wang, L. Kobzik, F.D. Moore, and H.B. Hechtman Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex Surgery 126 1999 343 348
17. J. Hill, T.F. Lindsay, F. Ortiz, C.G. Yeh, H.B. Hechtman, and F.D. Moore Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat J. Immunol. 149 1992 1723 1728
18. A. Stojadinovic, R. Smallridge, J. Nath, X. Ding, and T. Shea-Donohue Anti-inflammatory effects of U74389F in a rat model of intestinal ischemia/reperfusion injury Crit. Care Med. 27 1999 764 770
19. H. Tavaf-Motamen, T.J. Miner, B.W. Starnes, and T. Shea-Donohue Nitric oxide mediates acute lung injury by modulation of inflammation J. Surg. Res. 78 1998 137 142
20. S. Rehrig, S.D. Fleming, J. Anderson, J.M. Gutheridge, J. Rakstang, C. McQueen, V.M. Holers, G.C. Tsokos, and T. Shea-Donohue Complement inhibitor, Crry-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice J. Immunol. 167 2001 5921 5927
21. W.C. Conner, C.M. Gallagher, T.J. Miner, H. Tavaf-Motamen, K.M. Wolcott, and T. Shea-Donohue Neutrophil priming state predicts capillary leak after gut ischemia in rats J. Surg. Res. 84 1999 24 30
22. D.T. Ward, S.A. Lawson, C.M. Gallagher, W.C. Conner, and T. Shea-Donohue Sustained nitric oxide production via l-Arginine administration ameliorates effects of intestinal ischemia-reperfusion J. Surg. Res. 89 2000 13 19
23. S.A. Lawson, D.T. Ward, C. Conner, C.M. Gallagher, G. Tsokos, and T. Shea-Donohue Diabetic hyperglycemia: a facilitating factor in systemic capillary leak J. Surg. Res. 105 2002 95 101
24. G.L. Stahl, Y. Xu, L. Hao, M. Miller, J.A. Buras, M. Fung, and H. Zhao Role for the alternate complement pathway in ischemia/reperfusion injury Am. J. Pathol. 162 2003 449 455
25. S.D. Fleming, J. Anderson, F. Wilson, T. Shea-Donohue, and G.C. Tsokos C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion Clin. Immunol. 105 2003 55 64
26. G. Dietrich, S.V. Kaveri, and M.D. Kazatchkine Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network Clin. Immunol. Immunopathol. 62 1992 S73 S81
27. R.M. McMillan Leukotrienes in respiratory disease Paediatr. Respir. Rev. 2 2001 238 244
28. R.M. McMillan, and S.J. Foster Leukotriene B4 and inflammatory disease Agents Action 24 1988 114 119
29. S.D. Fleming, D. Mastellos, G. Karpel-Massler, T. Shea-Donohue, J.D. Lambris, and G.C. Tsokos C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury Clin. Immunol. 108 2003 263 273